STVN
Stevanato Group S.p.A.
NYSE · ITHealthcareMedical - Instruments & Supplies
$19.15-0.10%
Price as of Jul 20, 2026
STVN profitability
Stevanato Group S.p.A. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 29.0%
- EBITDA margin
- 24.5%
- EBIT margin
- 16.6%
- Net margin
- 11.7%
- Free cash flow margin
- -0.6%
Returns
- Return on equity
- 9.2%
- Return on assets
- 5.5%
- Return on invested capital
- 10.0%
- Asset turnover
- 0.47x
Cash efficiency
- Cash from operations
- $297.3M
- Cash per share
- $0.47
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.